[Bases of pharmacological therapy of essential hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002216:Captopril / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D008914:Minoxidil / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D008996:Monoamine Oxidase Inhibitors; D046948:Secologanin Tryptamine Alkaloids; D006830:Hydralazine; D008750:Methyldopa; D008914:Minoxidil; D002216:Captopril; D003000:Clonidine; D011224:Prazosin; D006145:Guanethidine
Basi di terapia farmacologica dell'ipertensione essenziale.